MedTrace Logo

Clinical Study of Glycosylated Extracellular Vesicles for Early Diagnosis of Breast Cancer

NCT05417048 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 420

Last updated 2023-02-23

No results posted yet for this study

Summary

This is a prospective, single-center, non-randomized, cohort study designed to evaluate the clinical diagnostic performance of glycosylated extracellular vesicles and their contents for early detection of breast cancer.

Conditions

Interventions

DIAGNOSTIC_TEST

Blood Sample

Up to 5mL of blood via venipuncture

Sponsors & Collaborators

  • Beijing Glyexo Gene Technology Co., Ltd.

    collaborator UNKNOWN

  • Peking University

    lead OTHER

Principal Investigators

  • Zhaoqing Fan, MD · Breast center at Peking University Cancer Hospital

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-07-14
Primary Completion
2023-12-15
Completion
2024-06-15

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05417048 on ClinicalTrials.gov